Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 51501-51550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04903353
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
PHASE4Recruiting
350 participants
Started: Feb 1, 2022 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04456569
Geniculate Artery Embolization for Osteoarthritis
NARecruiting
20 participants
Started: Feb 1, 2022 · Completed: Feb 1, 2026
4 conditions1 sponsor1 location
NCT05725993
Longitudinal Assessment of Traumatic Microvascular Injury-2
N/ARecruiting
110 participants
Started: Feb 1, 2022 · Completed: Mar 1, 2026
1 condition2 sponsors1 location
NCT06194695
DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma
N/ARecruiting
100 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT04975776
Sleep Restriction Therapy for Insomnia in Primary Health Care
NARecruiting
200 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04441983
Foot/Ankle At 7T MRI
N/ARecruiting
80 participants
Started: Feb 1, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06348446
Tacrolimus Exposure in Kidney Transplantation
N/ARecruiting
12,000 participants
Started: Feb 1, 2022 · Completed: Aug 30, 2024
1 condition2 sponsors4 locations
NCT05252897
Timing of Necrosectomy After Endoscopic Drainage of Walled-off Pancreatic Necrosis (WON)
NARecruiting
108 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT05183178
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
PHASE4Recruiting
16,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition7 sponsors1 location
NCT05235009
LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in Asymptomatic Adults (LEV87A)
N/ARecruiting
9,170 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04924088
Medical-legal Partnerships to Prevent Evictions and Homelessness Among Veterans
NARecruiting
300 participants
Started: Feb 1, 2022 · Completed: Oct 30, 2026
2 conditions2 sponsors1 location
NCT05559450
Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL
PHASE2Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
1 condition7 sponsors1 location
NCT05368987
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
NARecruiting
250 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05216809
Oral 'Breath Test' to Measure Anabolic Sensitivity in Young and Older Adults at Different Activity Levels
NARecruiting
32 participants
Started: Feb 1, 2022 · Completed: Mar 31, 2024
5 conditions1 sponsor1 location
NCT05235867
Secretin in Refeeding
N/ARecruiting
10 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04770870
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
NARecruiting
232 participants
Started: Feb 1, 2022 · Completed: Apr 30, 2029
3 conditions1 sponsor10 locations
NCT05214261
Laparoscopic-guided TAP Block vs Epidural Analgesia
NARecruiting
210 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07146256
Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry
N/ARecruiting
300 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2030
1 condition2 sponsors1 location
NCT04933370
Neuromodulation Parameter Efficacy
NARecruiting
20 participants
Started: Feb 1, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05169268
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
N/ARecruiting
10 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05503667
Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma
PHASE2Recruiting
96 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05953077
The Effect of Prior Learning on Treatment of Morpheme Errors
NARecruiting
32 participants
Started: Feb 1, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05241249
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
PHASE2Recruiting
37 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05146609
Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population
NARecruiting
1,384 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT04561986
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
PHASE3Recruiting
50 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2028
1 condition9 sponsors8 locations
NCT05142683
Effectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial
NARecruiting
300 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2027
1 condition3 sponsors1 location
NCT05262023
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
PHASE1/PHASE2Recruiting
106 participants
Started: Feb 1, 2022 · Completed: Nov 30, 2028
1 condition2 sponsors32 locations
NCT05138380
Hip Osteoarthritis and Foot Orthoses Trial (HOOT)
NARecruiting
28 participants
Started: Feb 1, 2022 · Completed: Oct 26, 2025
1 condition1 sponsor1 location
NCT05282381
Evaluation of Regret in Kidney Transplantation
N/ARecruiting
250 participants
Started: Feb 1, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05124457
DETERMINE: Detemir vs NPH
PHASE2Recruiting
336 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06533943
"Blue-green Space Physical Activity: the Parco Del Mare Study"
NARecruiting
30 participants
Started: Feb 1, 2022 · Completed: Dec 20, 2024
3 conditions1 sponsor1 location
NCT04461301
Multimodal Prehabilitation for Surgery in the Elderly: a Randomised, Prospective, Multicenter, Multidisciplinary Trial
NARecruiting
466 participants
Started: Feb 1, 2022 · Completed: Dec 30, 2026
2 conditions3 sponsors1 location
NCT05321355
Mainz Register of Patients With Sleep Disorders
N/ARecruiting
500 participants
Started: Feb 1, 2022 · Completed: Jan 31, 2030
9 conditions1 sponsor1 location
NCT04820335
Promoting Independence With Compensatory Cognitive Rehabilitation
NARecruiting
65 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05126823
Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients
NARecruiting
120 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05779319
1000 Eyes Lens Biometry Study: Artificial Intelligence for Intraocular Lens Power Calculation
N/ARecruiting
1,000 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors1 location
NCT05253495
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
PHASE2Recruiting
80 participants
Started: Feb 1, 2022 · Completed: Jun 30, 2028
2 conditions1 sponsor3 locations
NCT05760664
Exercises Directed To Dynamic Stiffness Of The Thoracolumbar Region And Performance Of Amateur Runners
NARecruiting
99 participants
Started: Feb 1, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT05282654
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
NARecruiting
1,300 participants
Started: Feb 1, 2022 · Completed: Oct 15, 2026
2 conditions2 sponsors2 locations
NCT03175718
INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients
NARecruiting
291 participants
Started: Feb 1, 2022 · Completed: Apr 28, 2026
2 conditions1 sponsor2 locations
NCT05146362
Vermont RETAIN Impact Evaluation
NARecruiting
2,040 participants
Started: Feb 1, 2022 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT05242055
Integrated Diagnosis and Treatment of CKD on Outcomes
N/ARecruiting
1,000 participants
Started: Feb 1, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT04773470
Implementation of FEES in Spinal Muscle Atrophy
NARecruiting
79 participants
Started: Feb 1, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05999370
Prehabilitation for Colorectal Cancer Patients With Low Functional Capacity and Malnutrition
NARecruiting
60 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05209737
Trendelenburg As a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients
NARecruiting
50 participants
Started: Jan 31, 2022 · Completed: Oct 20, 2026
2 conditions1 sponsor2 locations
NCT05034887
Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
64 participants
Started: Jan 31, 2022 · Completed: Mar 31, 2029
2 conditions2 sponsors1 location
NCT06844032
Predictors of Poor Prognosis in HFpEF
N/ARecruiting
400 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04900493
The Rett Syndrome Global Registry
N/ARecruiting
5,000 participants
Started: Jan 31, 2022 · Completed: Jun 30, 2031
1 condition7 sponsors1 location
NCT05162794
Is Laparoscopic Excision for Peritoneal Endometriosis Helpful or Harmful?
NARecruiting
100 participants
Started: Jan 31, 2022 · Completed: Jul 1, 2026
1 condition3 sponsors5 locations
NCT04149743
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
NARecruiting
420 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors2 locations